ES2067921T3 - Una biomasa y un procedimiento para la produccion de virus/antigeno de virus. - Google Patents

Una biomasa y un procedimiento para la produccion de virus/antigeno de virus.

Info

Publication number
ES2067921T3
ES2067921T3 ES91901647T ES91901647T ES2067921T3 ES 2067921 T3 ES2067921 T3 ES 2067921T3 ES 91901647 T ES91901647 T ES 91901647T ES 91901647 T ES91901647 T ES 91901647T ES 2067921 T3 ES2067921 T3 ES 2067921T3
Authority
ES
Spain
Prior art keywords
viruses
production
biomass
procedure
virus antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91901647T
Other languages
English (en)
Inventor
Wolfgang Mundt
Wilfried Woehrer
Friedrich Dorner
Johann Eibl
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oesterreichisches Institut fuer Haemoderivate
Original Assignee
Immuno AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immuno AG filed Critical Immuno AG
Application granted granted Critical
Publication of ES2067921T3 publication Critical patent/ES2067921T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24051—Methods of production or purification of viral material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/24011—Flaviviridae
    • C12N2770/24111—Flavivirus, e.g. yellow fever virus, dengue, JEV
    • C12N2770/24151—Methods of production or purification of viral material
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

LA INVENCION CONCIERNE A UNA BIOMASA PARA LA PRODUCCION DE VIRUS/ANTIGENOS DE VIRUS, QUE CONSTA DE GRUPOS CELULARES CON UN DIAMETRO ENTRE 100 (MU)M Y 1000 (MU)M. LA BIOMASA DE LA INVENCION POSEE EN SUSPENSION EN MEDIO DE CULTIVO UNA GRAN ACTIVIDAD METABOLICA Y ESTA INFECTADA CON VIRUS. PERMITE LA GRAN PRODUCCION TECNICA DE VIRUS/ANTIGENOS DE VIRUS PUROS Y ES APROPIADA ESPECIALMENTE PARA LA PRODUCCION DE VIRUS FSMEÑANTIGENOS DE VIRUS.
ES91901647T 1990-01-04 1991-01-03 Una biomasa y un procedimiento para la produccion de virus/antigeno de virus. Expired - Lifetime ES2067921T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
AT18/90A AT393277B (de) 1990-01-04 1990-01-04 Verfahren zur herstellung von fruehsommer- meningoenzephalitis-virus (fsme-virus)-antigen

Publications (1)

Publication Number Publication Date
ES2067921T3 true ES2067921T3 (es) 1995-04-01

Family

ID=3479351

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91901647T Expired - Lifetime ES2067921T3 (es) 1990-01-04 1991-01-03 Una biomasa y un procedimiento para la produccion de virus/antigeno de virus.

Country Status (17)

Country Link
US (2) US5391491A (es)
EP (1) EP0509008B1 (es)
JP (1) JP2633392B2 (es)
AT (2) AT393277B (es)
CA (1) CA2073168C (es)
CZ (1) CZ279725B6 (es)
DE (1) DE59103696D1 (es)
DK (1) DK0509008T3 (es)
ES (1) ES2067921T3 (es)
FI (1) FI106241B (es)
HR (1) HRP921353A2 (es)
HU (1) HU212597B (es)
NO (1) NO310472B1 (es)
RU (1) RU2099419C1 (es)
SK (1) SK279200B6 (es)
WO (1) WO1991009937A1 (es)
YU (1) YU391A (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5719051A (en) * 1989-12-22 1998-02-17 Immuno Aktiengesellschaft Perfusion system and a method for the large scale production of virus or virus antigen
AT393277B (de) * 1990-01-04 1991-09-25 Immuno Ag Verfahren zur herstellung von fruehsommer- meningoenzephalitis-virus (fsme-virus)-antigen
US5698433A (en) * 1994-11-10 1997-12-16 Immuno Ag Method for producing influenza virus and vaccine
US6146873A (en) * 1994-11-10 2000-11-14 Baxter Aktiengesellschaft Production of orthomyxoviruses in monkey kidney cells using protein-free media
US5756341A (en) * 1994-11-10 1998-05-26 Immuno Ag Method for controlling the infectivity of viruses
DK0791055T3 (da) 1994-11-10 2012-04-16 Baxter Healthcare Sa Fremgangsmåde til fremstilling af biologiske produkter i proteinfri kultur
US5753489A (en) * 1994-11-10 1998-05-19 Immuno Ag Method for producing viruses and vaccines in serum-free culture
DE19612966B4 (de) 1996-04-01 2009-12-10 Novartis Vaccines And Diagnostics Gmbh & Co. Kg MDCK-Zellen und Verfahren zur Vermehrung von Influenzaviren
BR9804283B1 (pt) * 1998-03-18 2010-11-30 processo para a produção de flavivìrus em baixa densidade de células em cultura e processo para a produção de flavivìrus recombinante em baixa densidade de células em cultura.
US7445924B2 (en) * 2000-11-23 2008-11-04 Bavarian Nordic A/S Modified Vaccinia Ankara virus variant and cultivation method
DE10144906B4 (de) 2001-09-12 2013-11-28 Novartis Vaccines And Diagnostics Gmbh Verfahren zur großtechnischen Herstellung von Impfstoffen
US20040023358A1 (en) * 2001-12-21 2004-02-05 Wyeth Avian embryo particulate biomass for the production of virus antigens
ATE393212T2 (de) * 2002-09-05 2008-05-15 Bavarian Nordic As Verfahren zur amplifikation von einem poxvirus in serumfreien verhältnissen
US7998488B2 (en) * 2008-11-14 2011-08-16 Baxter International Inc. Vaccine formulations and uses thereof
CN103200962A (zh) 2010-09-23 2013-07-10 巴克斯特国际公司 重组病毒载体及用于诱导对黄热病毒的免疫反应的方法
AU2012212463B2 (en) 2011-01-31 2016-07-07 Nanotherapeutics, Inc. Recombinant viral vectors and methods for inducing a heterosubtypic immune response to influenza A viruses

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4059485A (en) * 1976-11-03 1977-11-22 Monsanto Company Adaptation of cell lines to suspension culture
US4195130A (en) * 1978-04-20 1980-03-25 Cornell Research Foundation, Inc. Propagation of feline infectious peritonitis virus in tissue cultures
AT358167B (de) * 1978-12-22 1980-08-25 Immuno Ag Verfahren zur herstellung von fruehsommer- -meningoenzephalitis-virus (fsme-virus)- -vakzinen
US4335215A (en) * 1980-08-27 1982-06-15 Monsanto Company Method of growing anchorage-dependent cells
AT393277B (de) * 1990-01-04 1991-09-25 Immuno Ag Verfahren zur herstellung von fruehsommer- meningoenzephalitis-virus (fsme-virus)-antigen
US5114855A (en) * 1990-04-19 1992-05-19 Regents Of The University Of Minnesota Method for aggregating cells with small microspheres

Also Published As

Publication number Publication date
US5550051A (en) 1996-08-27
JPH05503843A (ja) 1993-06-24
FI923099A (fi) 1992-07-03
ATA1890A (de) 1991-02-15
EP0509008B1 (de) 1994-11-30
JP2633392B2 (ja) 1997-07-23
FI106241B (fi) 2000-12-29
US5391491A (en) 1995-02-21
ATE114713T1 (de) 1994-12-15
DE59103696D1 (de) 1995-01-12
HU212597B (en) 1996-08-29
SK279200B6 (sk) 1998-07-08
CA2073168A1 (en) 1991-07-05
FI923099A0 (fi) 1992-07-03
DK0509008T3 (da) 1995-04-18
HUT64583A (en) 1994-01-28
NO922622D0 (no) 1992-07-02
CZ279725B6 (cs) 1995-06-14
WO1991009937A1 (de) 1991-07-11
NO922622L (no) 1992-07-23
AT393277B (de) 1991-09-25
YU391A (sh) 1994-04-05
RU2099419C1 (ru) 1997-12-20
CS9100012A2 (en) 1991-08-13
NO310472B1 (no) 2001-07-09
EP0509008A1 (de) 1992-10-21
HRP921353A2 (en) 1995-10-31
CA2073168C (en) 1999-04-27

Similar Documents

Publication Publication Date Title
ES2067921T3 (es) Una biomasa y un procedimiento para la produccion de virus/antigeno de virus.
ES2154051T3 (es) Procedimiento para la preparacion de particulas de polimero.
ES2067528T3 (es) Lineas celulares continuas en la produccion de vbi.
DE59007374D1 (de) Optisch gegengekoppelter Verstärker.
MX9203439A (es) Una citocina mamifera, il-11
ES2038168T3 (es) Ceolitas ligadas y procedimiento para su preparacion.
ES2109254T3 (es) Proteinas antigenas y vacunas que las contienen para la prevencion de cocidiosis.
AR246769A1 (es) Fibras termosoldables, y articulos fabricados soldados termicamente y textiles no tejidos obtenidos de dichas fibras
FI891283A0 (fi) Ifosfamid-mesna-lyofilisat och foerfarande foer dess framstaellning.
ES2165872T3 (es) Modulacion del sistema inmunologico utilizando psoralenos activados por luz visible.
ES2185618T3 (es) Medio exento de suero para celulas de mamifero.
ITTO920133A1 (it) Separatore
NO307500B1 (no) Steril, bufret, i det vesentlige isotonisk saltvannsoppløsning
KR830005871A (ko) 광견병 백신의 제조방법
FI880636A0 (fi) Foerfarande foer inaktivering av med hoelje foersedda virus i en medelst en cell in vitro framstaellda proteinprodukter.
MX9300071A (es) Liberacion de componentes intracelulares.
FI922710A0 (fi) Eliminering av aktiverade lymfocyter.
ES2066422T3 (es) Expresion de un arn multigenes con actividad de autoempalme.
ES2089086T3 (es) Criba para la separacion selectiva de materiales con diferencia de pesos.
ATE76757T1 (de) Impfstoff gegen herpes simplex.
ES2105296T3 (es) Procedimiento de amplificacion de agentes infecciosos para diagnostico "in vitro" sobre cultivos celulares que contienen mycoplasmas.
FR2660197B1 (fr) Anticorps purifies specifiquement diriges contre les lipopolysaccharides (lps) des bacteries gram negatif.
FR2630456B1 (fr) Milieu de culture, notamment utilisable en culture in vitro et en bacteriologie; son procede de preparation
EP0345559A3 (en) Hiv-2 variants
SE8605535L (sv) Cellsystem, dess framstellning och anvendning

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 509008

Country of ref document: ES